Publisher Correction: Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance

Sci Rep. 2022 Mar 22;12(1):4879. doi: 10.1038/s41598-022-09014-1.

Anyue Yin^{1

2}, Johan G C van Hasselt³, Henk-Jan Guchelaar^{1

2}, Lena E Friberg⁴, Dirk Jan A R Moes^{5

6}

¹ Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
² Leiden Network for Personalized Therapeutics, Leiden University Medical Center, Leiden, The Netherlands.
³ Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, The Netherlands.
⁴ Department of Pharmacy, Uppsala University, Uppsala, Sweden.
⁵ Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. D.J.A.R.Moes@lumc.nl.
⁶ Leiden Network for Personalized Therapeutics, Leiden University Medical Center, Leiden, The Netherlands. D.J.A.R.Moes@lumc.nl.

No abstract available

Publication types